Evidence map›Paper›PMID 31216451›Full record

ArticleJournal of pharmaceutical sciences2019

Effect of Iron Oxide Nanoparticles on the Oxidation and Secondary Structure of Growth Hormone.

Ninad Varkhede, Björn-Hendrik Peters, Yangjie Wei, C Russell Middaugh, Christian Schöneich, M Laird Forrest

Open access · greenAbstract read
In one paragraph

Article in Journal of pharmaceutical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Analysis of NAnalytical biochemistry · 2021
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ninad VarkhedeDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047.
Björn-Hendrik PetersDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047.
Yangjie WeiDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047.
C Russell MiddaughDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047.
Christian SchöneichDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047.
M Laird ForrestDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047. Electronic address: lforrest@ku.edu.
University of Kansas · US

Funding

Biomaterials for treatment of head and neck cancerR01CA173292 · NCI · UNIVERSITY OF KANSAS LAWRENCE · PI FORREST, MARCUS LAIRD · 2013 to 2017
$1.4M
NCI NIH HHS R01 CA173292
6 · The paper itself

Abstract

Oxidation of therapeutic proteins (TPs) can lead to changes in their pharmacokinetics, biological activity and immunogenicity. Metal impurities such as iron are known to increase oxidation of TPs, but nanoparticulate metals have unique physical and chemical properties compared to the bulk material or free metal ions. Iron oxide nanoparticles (IONPs) may originate from equipment used in the manufacturing of TPs or from needles during injection. In this study, the impact of IONPs on oxidation of a model protein, rat growth hormone (rGH), was investigated under chemical stress. Hydrogen peroxide (H

Indexed as

Amino AcidsAnimalsCircular DichroismFerric CompoundsGrowth HormoneHydrogen PeroxideIronNanoparticlesOxidation-ReductionProtein Conformation, alpha-HelicalProtein Structure, SecondaryRatsAmino AcidsFerric Compoundsferric oxideGrowth HormoneHydrogen PeroxideIroniron oxide nanoparticlesmass spectrometrymethionineoxidationproteinsecondary structure

Identifiers

PMID31216451
PMCPMC6759409
OpenAlexW2952051839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.